Abstract:Anticancer activities of platinum (II) complexes are modulated by the chelated phosphine ligands, with more azadiphosphines resulting in more cytotoxicity. This work reports the preparations and anticancer activities of a set of platinum (II) complexes. Two types of bidentate ligands, azadiphosphine (PNP) and diphosphine (PP), were applied to afford different kinds of platinum centers, the homoleptic complexes, [Pt (PNP)2]2+ (1 and 2) and [Pt (PP)2]2+ (4), and the hybrid complex, [Pt (PNP)(PP)]2+ (3). All these complexes are characterized by various analytical techniques, and their structures were validated using single‐crystal X‐ray diffraction analysis. Notably, the stability of the complexes 1–4 is differentiated both in phosphate‐buffered saline (PBS) and in the culture media (RPMI‐1640), relative to the type of coordinated diphosphine ligands, specifically, the more PNP ligands, the less stability. The bite angles of P‐Pt‐P bonds in 1–4 would be reliant on their stability, so that complexes 1 and 2 with small bite angles tend to be labile. A mechanistic understanding on the decomposition of 2 is proposed with the aid of mass analysis. As a result, their anticancer activities should be also associated with their stability so that the chelated ligands, with more PNP ligands, lead to more cytotoxicity. Mechanistically, the poisonous platinum (II) derivatives of complex 2 should interact with the nucleus DNA, whereas the intact complex 4 is not traceable, confirming from a γ‐H2AX‐related immunofluorescence staining kit. Additionally, complex 2 exhibits severe toxicity toward several cancer cells as well as a normal cell. Furthermore, complex 2 has inhibited the formation and viability of three‐dimensional T24 mammospheres, reminding it of a promising candidate for anticancer treatments. Overall, the present work provides a way for the systematic investigation to elucidate how a bidentate diphosphine ligand modulates the stability and the anticancer activities of the corresponding square‐planner platinum (II) complex.

Exploring the Hydrolytic Behavior of the Platinum(IV) Complexes with Axial Acetato Ligands

Synthesis, characterization, and cytotoxicity of new types of binuclear platinum(II) complexes

Synthesis and biological evaluation of water-soluble trans-[bicyclo[2.2.2]octane-7R,8R-diamine]platinum(II) complexes with linear or branched alkoxyacetates as leaving groups

Synthesis, Reactivity Studies and Cytotoxicity of Two Iodidoplatinum(II) Complexes. Does Photoactivation Work?

Anticancer Potency of Platinum(Ii) Complexes Containing Both Chloride Anion and Chelated Carboxylate As Leaving Groups

Design, Synthesis and Anticancer Activity of Diam(m)ine Platinum(ii) Complexes Bearing a Small-Molecular Cell Apoptosis Inducer Dichloroacetate

Hydrolysis Mechanisms of Trans Platinum-Based Anticancer Drug with Heterocyclic Amine Ligands:A Comparative DFT Study

Stereospecific and Kinetic Control over the Hydrolysis of A Sterically Hindered Platinum Picoline Anticancer Complex

Potent Anticancer Activity and Possible Low Toxicity of Platinum(ii) Complexes with Functionalized 1,1-Cyclobutanedicarboxylate As a Leaving Ligand.

Synthesis and Antitumor Activity of (3-Hydroxyacrylato-o,o′) Diammineplatinum(II)

Antitumor Platinum(ii) Complexes of N-monoalkyl 1R,2r-Diamino-cyclohexanes with 3-(Nitrooxy)cyclobutane-1,1-dicarboxylate As a Leaving Group.

Design, Synthesis, and Biological Features of Platinum(Ii) Complexes with Rigid Steric Hindrance

In Vitro Biological Evaluation of Platinum(ii) Complexes with 1-(Methoxy Substituted Benzyl) Azetidine-3,3-dicarboxylato Ligands.

Improve the anticancer potency of the platinum(II) complexes through functionalized leaving group

In vitro cytotoxicity activity of platinum(II) complexes with alkyl-branched/cyclic alkoxyacetates as leaving ligands

Modulating the Anticancer Activity of Square‐Planar Platinum (II) Complex by Its Chelated Diphosphine

Application Of High Performance Capillary Electrophoresis Tandem Mass Spectrometry To The Investigation On The Stability Of Novel Anticancer Platinum Complex In Solution

Insight into the Antitumor Actions of Sterically Hindered Platinum(ii) Complexes by a Combination of STD NMR and LCMS Techniques.

Design, Synthesis and in Vitro Cytotoxicity of Novel Dinuclear Platinum(Ii) Complexes

Synthesis,characterization and cytotoxicity of platinum (Ⅱ) complexes with 2-methyl-2-substituted phenoxypropanoic acid as leaving ligands

Noncovalent Interactions Between a Trinuclear Monofunctional Platinum Complex and Human Serum Albumin.